Aimee E. Houlton

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide

Claire Harrison, Adam J. Mead, Anesh Panchal et al. · Blood · 2017 · 163 citations · Full text

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

Charles Craddock, Aimee E. Houlton, Lynn Quek et al. · Clinical Cancer Research · 2017 · 85 citations · Full text

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Jennifer Pascoe, Aimee E. Houlton, Charlotte Gaskell et al. · Research Square (Research Square) · 2021 · 78 citations · Full text

Cancer Management, Pharmacotherapy, Beta-hydroxy Beta-methylbutyrate/arginine/glutamine +16

Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial

Kailash Krishnan, S. F. Mukhtar, James Lingard et al. · Journal of Neurology Neurosurgery & Psychiatry · 2015 · 40 citations · Full text

Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer

San Soo Hoo, Natalie Marriott, Aimee E. Houlton et al. · International Journal of Gynecological Cancer · 2015 · 29 citations